Zoekresultaten - Olav Dalgård

Verfijn jouw resultaten
  1. 1
    Follow‐Up Studies of Treatment for Hepatitis C Virus Infection among Injection Drug Users

    Follow‐Up Studies of Treatment for Hepatitis C Virus Infection among Injection Drug Users door Olav Dalgård

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs

    Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs door Bart Grady, Janke Schinkel, Xiomara V. Thomas, Olav Dalgård

    Gepubliceerd in 2013
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study

    All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study door Knut Boe Kielland, Kjell Skaug, Ellen J. Amundsen, Olav Dalgård

    Gepubliceerd in 2012
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection

    Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection door Olav Dalgård, Atle Egeland, Kjell Skaug, Kostas Vilimas, Tore W. Steen

    Gepubliceerd in 2004
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study

    Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study door Håvard Midgard, Jørgen G. Bramness, Svetlana Skurtveit, John Willy Haukeland, Olav Dalgård

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

    Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy door Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, B Myrvang, Trine Bjøro, Egil Haug, H. Bell

    Gepubliceerd in 2002
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study

    Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study door Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, Bjørn Myrvang, S Ritland, Kjell Skaug, N Raknerud, Helge Bell

    Gepubliceerd in 2004
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    HCV epidemiology in high-risk groups and the risk of reinfection

    HCV epidemiology in high-risk groups and the risk of reinfection door Håvard Midgard, Amanda Weir, Norah Palmateer, Vincent Lo Re, Juan A. Pineda, Juan Macı́as, Olav Dalgård

    Gepubliceerd in 2016
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C

    Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C door Jason Grebely, Tracy Swan, Matthew Hickman, Julie Bruneau, Philip Bruggmann, Olav Dalgård, Alain H. Litwin, Markus Backmund, Gregory J. Dore

    Gepubliceerd in 2017
    Volledige tekst
    Carta
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics

    A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics door Magnus Nakrem Lyngbakken, Jan-Erik Berdal, Arne Nørgaard Eskesen, Dag Kvale, Inge Christoffer Olsen, Corina S. Rueegg, Anbjørg Rangberg, Christine Monceyron Jonassen, Torbjørn Omland, Helge Røsjø, Olav Dalgård

    Gepubliceerd in 2020
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B

    630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B door Alessandra Mangia, Olav Dalgård, N. Minerva, Hans Verbaan, Gaetano Scotto, Donato Bacca, Ernesto Agostinacchio, Kristian Bjøro, Vito Carretta, Valeria Piazzolla, Raffaele Cozzolongo, Marco Romano, Leonardo Mottola, Angelo Andriulli

    Gepubliceerd in 2009
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

    Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis door Behzad Hajarizadeh, Evan B. Cunningham, Heather Valerio, Marianne Martinello, Matthew Law, Naveed Z. Janjua, Håvard Midgard, Olav Dalgård, John Dillon, Matthew Hickman, Julie Bruneau, Gregory J. Dore, Jason Grebely

    Gepubliceerd in 2019
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    CMV drives clonal expansion of NKG2C<sup>+</sup> NK cells expressing self‐specific KIRs in chronic hepatitis patients

    CMV drives clonal expansion of NKG2C<sup>+</sup> NK cells expressing self‐specific KIRs in chronic hepatitis patients door Vivien Béziat, Olav Dalgård, Tarik Asselah, Philippe Halfon, Pierre Bédossa, Ali Boudifa, B. Hervier, Ioannis Théodorou, Michelle Martinot, Patrice Debré, Niklas K. Björkström, Karl‐Johan Malmberg, Patrick Marcellin, Vincent Vieillard

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response door Olav Dalgård, Kristian Bjro, Helmer Ring‐Larsen, Einar S. Björnsson, Mona Holberg‐Petersen, Eva Skovlund, Olle Reichard, B Myrvang, Bo Sundelöf, S Ritland, Kjell B. Hellum, Aril Frydén, Jon Florholmen, Hans Verbaan

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

    Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV) door Lars Thore Fadnes, Christer Frode, Jørn Henrik Vold, Christian Ohldieck, Rafael Alexander Leiva, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else‐Marie Løberg, Kjell Arne Johansson

    Gepubliceerd in 2019
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)

    Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV) door Lars Thore Fadnes, Christer Frode, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else‐Marie Løberg, Kjell Arne Johansson

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

    Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs door Geert Robaeys, Jason Grebely, Stefan Mauss, Philip Bruggmann, J. Moussalli, Andrea De Gottardi, Tracy Swan, Amber Arain, Achim Kautz, Heino Stöver, Heiner Wedemeyer, Martin Schaefer, Lynn E. Taylor, Markus Backmund, Olav Dalgård, Maria Prins, Gregory J. Dore

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination

    The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination door Kelly Safreed‐Harmon, Sarah Blach, Soo Aleman, Signe Bollerup, Graham Cooke, Olav Dalgård, John Dillon, Gregory J. Dore, Ann‐Sofi Duberg, Jason Grebely, Knut Boe Kielland, Håvard Midgard, Kholoud Porter, Homie Razavi, Mark Tyndall, Nina Weis, Jeffrey V. Lazarus

    Gepubliceerd in 2019
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

    Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework door Emma Day, Margaret Hellard, Carla Treloar, Julie Bruneau, Natasha K. Martin, Anne Øvrehus, Olav Dalgård, Andrew R. Lloyd, John Dillon, Matthew Hickman, Jude Byrne, Alain H. Litwin, Mojca Matičič, Philip Bruggmann, Håvard Midgard, Brianna L. Norton, Stacey Trooskin, Jeffrey V. Lazarus, Jason Grebely

    Gepubliceerd in 2018
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Recommendations for the management of hepatitis C virus infection among people who inject drugs

    Recommendations for the management of hepatitis C virus infection among people who inject drugs door Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgård, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain H. Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore

    Gepubliceerd in 2015
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: